New insights into the pathophysiology of gestational diabetes mellitus: Possible role of human leukocyte antigen-G

Medical Hypotheses

Volumn 69, Issue 3, 2007, Pages 526-530

  Öztekin, Özer ^a  

^a PAMUKKALE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

HLA G ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PLACENTA LACTOGEN;

ADIPOSE TISSUE; ANTIGEN EXPRESSION; ANTIGEN FUNCTION; ARTICLE; CYTOTOXIC T LYMPHOCYTE; DIABETOGENESIS; DOWN REGULATION; HIGH RISK POPULATION; HUMAN; PANCREAS ISLET CELL; PATHOPHYSIOLOGY; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL;

ADIPOSE TISSUE; AUTOIMMUNITY; DIABETES, GESTATIONAL; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; IMMUNE SYSTEM; INFLAMMATION; MODELS, BIOLOGICAL; MODELS, THEORETICAL; NF-KAPPA B; PREGNANCY; PREGNANCY COMPLICATIONS; TRANSCRIPTION FACTORS;

EID: 34447272265     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2007.01.054     Document Type: Article

References (42)

1. Cunningham F.G., et al. Chapter 52: Diabetes. Williams Obstetrics. 22nd ed. (2005), McGraw-Hill, US
2. Atègbo J.M., Grissa O., Yessoufou A., et al. Modulation of adipokines and cytokines in gestational diabetes and macrosomia. J Clin Endocrinol Metab 91 10 (2006) 4137-4143
3. Bjorntorp P. Neuroendocrine perturbations as a cause of insulin resistance. Diabetes Metab Res Rev 15 6 (1999) 427-441
4. Andrews R.C., and Walker B.R. Glucocorticoids and insulin resistance: old hormones, new targets. Clin Sci 96 5 (1999) 513-523
5. Cirulli V., Zalatan J., McMaster M., Prinsen R., Salomon D.R., Ricordi C., et al. The class I HLA repertoire of pancreatic islets comprises the nonclassical class Ib antigen HLA-G. Diabetes 55 5 (2006) 1214-1222
6. Kopp E.B., and Ghosh S. NF-kappa B and rel proteins in innate immunity. Adv Immunol 58 (1995) 1-27
7. Havel P.J. Update on adipocyte hormones: regulation of energy balance and carbohydrate/lipid metabolism. Diabetes 53 (2004) 143-151
8. Kralisch S., Klein J., Bluher M., et al. Therapeutic perspectives of adipocytokines. Expert Opin Pharmacother 6 6 (2005) 863-872
9. Bershtein L.M., Shemerovskaya T.G., Sofronov B.N., et al. Antibody formation to cell membranes of adipose tissue in human blood serum. Bull Exp Biol Med 112 7 (1992) 83-85
10. Herder C., Illig T., Rathmann W., et al., KORA Study Group. Inflammation and type 2 diabetes: results from KORA Augsburg. Gesundheitswesen 67 Suppl. 1 (2005) 115-121
11. Greenberg A.S., and McDaniel M.L. Identifying the links between obesity, insulin resistance and beta-cell function: potential role of adipocyte-derived cytokines in the pathogenesis of type 2 diabetes. Eur J Clin Invest 32 Suppl. 3 (2002) 24-34
12. Tilg H., and Moschen A.R. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 6 10 (2006) 772-783
13. Wolf M., Sauk J., Shah A., et al. Inflammation and glucose intolerance: a prospective study of gestational diabetes mellitus. Diabetes Care 27 (2004) 21-27
14. Yuan M., Konstantopoulos N., Lee J., Hansen L., Li Z.W., Karin M., et al. Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science 293 5535 (2001) 1673-1677
15. Cai D., Yuan M., Frantz D.F., Melendez P.A., Hansen L., Lee J., et al. Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat Med 11 2 (2005) 183-190
16. Arkan M.C., Hevener A.L., Greten F.R., Maeda S., Li Z.W., Long J.M., et al. IKK-beta links inflammation to obesity-induced insulin resistance. Nat Med 11 2 (2005) 191-198
17. Chen F. Is NF-kappaB a culprit in type 2 diabetes?. Biochem Biophys Res Commun 332 1 (2005) 1-3
18. Hunt J.S., Petroff M.G., McIntire R.H., and Ober C. HLA-G and immune tolerance in pregnancy. FASEB J 19 7 (2005) 681-693
19. Morales P.J., Pace J.L., Platt J.S., Phillips T.A., Morgan K., Fazleabas A.T., et al. Placental cell expression of HLA-G2 isoforms is limited to the invasive trophoblast phenotype. J Immunol 171 11 (2003) 6215-6224
20. Wilczynski J.R. Immunological analogy between allograft rejection, recurrent abortion and pre-eclampsia - the same basic mechanism?. Hum Immunol 67 7 (2006) 492-511
21. Kasiske B.L., Snyder J.J., Gilbertson D., et al. Diabetes mellitus after kidney transplantation in the United States. Am J Transplant 3 (2003) 178
22. Cosio F.G., Pesavento T.E., Osei K., et al. Post-transplant diabetes mellitus increasing incidence in renal allograft recipients transplanted in recent years. Kidney Int 59 (2001) 732
23. Sezer S., Akgul A., Altinoglu A., et al. Posttransplant diabetes mellitus: impact of good blood glucose regulation on renal transplant recipient outcome. Transplant Proc 38 2 (2006) 533-536
24. Bayes B., Lauzurica R., Granada M.L., et al. Adiponectin and risk of new-onset diabetes mellitus after kidney transplantation. Transplantation 78 1 (2004) 26-30
25. Qiu J., Terasaki P.I., Miller J., Mizutani K., Cai J., and Carosella E.D. Soluble HLA-G expression and renal graft acceptance. Am J Transplant 6 9 (2006) 2152-2156
26. Luque J., Torres M.I., Aumente M.D., et al. Soluble HLA-G in heart transplantation: their relationship to rejection episodes and immunosuppressive therapy. Hum Immunol 67 4-5 (2006) 257-263
27. Basturk B., Karakayali F., Emiroglu R., et al. Human leukocyte antigen-G, a new parameter in the follow-up of liver transplantation. Transplant Proc 38 2 (2006) 571-574
28. Lila N., Amrein C., Guillemain R., et al. Human leukocyte antigen-G expression after heart transplantation is associated with a reduced incidence of rejection. Circulation 105 16 (2002) 1949-1954
29. LeMaoult J., Le Discorde M., Rouas-Freiss N., et al. Biology and functions of human leukocyte antigen-G in health and sickness. Tissue Antigens 62 (2003) 273
30. Fuzzi B., Rizzo R., Criscuoli L., et al. HLA-G expression in early embryos is a fundamental prerequisite for the obtainment of pregnancy. Eur J Immunol 32 (2002) 311
31. Ober C. HLA-G: an asthma gene on chromosome 6p. Immunol Allergy Clin North Am 25 4 (2005) 669-679
32. Hviid T.V., and Christiansen O.B. Linkage disequilibrium between human leukocyte antigen (HLA) class II and HLA-G-possible implications for human reproduction and autoimmune disease. Hum Immunol 66 6 (2005) 688-699
33. Mallone R., and Perin P.C. Anti-CD38 autoantibodies in type? diabetes. Diabetes Metab Res Rev 22 4 (2006) 284-294
34. Antonelli A., Tuomi T., Nannipieri M., Fallahi P., Nesti C., Okamoto H., et al. Autoimmunity to CD38 and GAD in type I and type II diabetes: CD38 and HLA genotypes and clinical phenotypes. Diabetologia 45 9 (2002) 1298-1306
35. Romkens T.E., Kusters G.C., Netea M.G., and Netten P.M. Prevalence and clinical characteristics of insulin-treated, anti-GAD-positive, type 2 diabetic subjects in an outpatient clinical department of a Dutch teaching hospital. Neth J Med 64 4 (2006) 114-118
36. Genovese S., Bazzigaluppi E., Goncalves D., Ciucci A., Cavallo M.G., Purrello F., et al. Clinical phenotype and beta-cell autoimmunity in Italian patients with adult-onset diabetes. Eur J Endocrinol 154 3 (2006) 441-447
37. Kent S.C., Chen Y., Bregoli L., Clemmings S.M., Kenyon N.S., Ricordi C., et al. Expanded T cells from pancreatic lymph nodes of type 1 diabetic subjects recognize an insulin epitope. Nature 435 (2005) 224-228
38. Gobin S.J., Biesta P., de Steenwinkel J.E., et al. HLA-G transactivation by cAMP-response element-binding protein (CREB). An alternative transactivation pathway to the conserved major histocompatibility complex (MHC) class I regulatory routes. J Biol Chem 277 42 (2002) 39525-39531
39. Zhong H., May M.J., Jimi E., et al. The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1. Mol Cell 9 (2002) 625-636
40. Finn P.W., Stone J.R., Boothby M.R., and Perkins D.L. Inhibition of NF-kappaB-dependent T cell activation abrogates acute allograft rejection. J Immunol 167 10 (2001) 5994-6001
41. Beg A.A., Sha W.C., Bronson R.T., Ghosh S., and Baltimore D. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature 376 6536 (1995) 167-170
42. Fournel S., Aguerre-Girr M., Huc X., Lenfant F., Alam A., Toubert A., et al. Cutting edge: soluble HLA-G1 triggers CD95/CD95 ligand-mediated apoptosis in activated CD8+ cells by interacting with CD8. J Immunol 164 12 (2000) 6100-6104